| scholarly article | Q13442814 |
| P50 | author | Rebecca J. Baer | Q63351116 |
| James G Anderson | Q86208637 | ||
| Laura L. Jelliffe-Pawlowski | Q115920826 | ||
| P2093 | author name string | Elizabeth E Rogers | |
| Kelli K Ryckman | |||
| Matthew S Pantell | |||
| J Colin Partridge | |||
| Larry Rand | |||
| Martina A Steurer | |||
| Scott P Oltman | |||
| P2860 | cites work | Intensive care for extreme prematurity--moving beyond gestational age | Q24649168 |
| Maternal protein-energy malnutrition during early pregnancy in sheep impacts the fetal ornithine cycle to reduce fetal kidney microvascular development. | Q30596717 | ||
| Accurate prediction of gestational age using newborn screening analyte data | Q31014380 | ||
| Limits of human viability in the United States: a medicolegal review | Q34230747 | ||
| Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network | Q34315813 | ||
| Medical staff guidelines for periviability pregnancy counseling and medical treatment of extremely premature infants | Q34482138 | ||
| Short term outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the EPICure studies). | Q34501470 | ||
| Changes in mortality and morbidities among infants born at less than 25 weeks during the post-surfactant era | Q35296339 | ||
| Between-hospital variation in treatment and outcomes in extremely preterm infants. | Q35733557 | ||
| Clinical and environmental influences on metabolic biomarkers collected for newborn screening. | Q36501266 | ||
| Swiss medical centres vary significantly when it comes to outcomes of neonates with a very low gestational age. | Q36555203 | ||
| Predicting gestational age using neonatal metabolic markers | Q36731296 | ||
| Gestational dating by metabolic profile at birth: a California cohort study | Q36770344 | ||
| Glucose regulation in preterm newborn infants | Q36857894 | ||
| Association of amino acids with common complications of prematurity | Q36864043 | ||
| Daily mortality of infants born at less than 30weeks' gestation | Q36889088 | ||
| Intraventricular hemorrhage in neonates born before 32 weeks of gestation-retrospective analysis of risk factors | Q37139321 | ||
| Intracranial hemorrhage in the preterm infant: understanding it, preventing it. | Q37640534 | ||
| Extremely high phenylalanine levels in a newborn on parenteral nutrition: phenylketonuria in the neonatal intensive care unit | Q37895456 | ||
| Biological mechanisms for nutritional regulation of maternal health and fetal development | Q38022303 | ||
| Survival and Major Morbidity of Extremely Preterm Infants: A Population-Based Study | Q38407324 | ||
| Acylcarnitine Profiles Reflect Metabolic Vulnerability for Necrotizing Enterocolitis in Newborns Born Premature | Q39194763 | ||
| Metabolomics of prematurity: analysis of patterns of amino acids, enzymes, and endocrine markers by categories of gestational age. | Q39317447 | ||
| Trends in hospitalization of preterm infants with intraventricular hemorrhage and hydrocephalus in the United States, 2000-2010. | Q40348910 | ||
| Neonatal deaths: prospective exploration of the causes and process of end-of-life decisions | Q40647634 | ||
| Survival and morbidity of preterm children born at 22 through 34 weeks' gestation in France in 2011: results of the EPIPAGE-2 cohort study | Q41526049 | ||
| Carnitine transport and fatty acid oxidation | Q41633875 | ||
| Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. | Q43777978 | ||
| Alanine administration does not stimulate gluconeogenesis in preterm infants | Q44536700 | ||
| Birth prevalence of disorders detectable through newborn screening by race/ethnicity. | Q44587834 | ||
| Reduction in newborn screening metabolic false-positive results following a new collection protocol. | Q44665599 | ||
| Antenatal prediction of neonatal mortality in very premature infants | Q46317037 | ||
| Short-term outcome after active perinatal management at 23-25 weeks of gestation. A study from two Swedish tertiary care centres. Part 2: infant survival | Q46346024 | ||
| Prediction of death for extremely premature infants in a population-based cohort. | Q46382237 | ||
| Risk factors and estimation tool for death among extremely premature infants: a national study | Q46469077 | ||
| United States birth weight reference corrected for implausible gestational age estimates | Q47174566 | ||
| Day-by-day postnatal survival in very low birth weight infants | Q47424187 | ||
| National variability in neonatal resuscitation practices at the limit of viability | Q48174970 | ||
| Improving survival of extremely preterm infants born between 22 and 25 weeks of gestation. | Q51352028 | ||
| Limits of viability: definition of the gray zone. | Q51875305 | ||
| 1H NMR-based metabolomic analysis of urine from preterm and term neonates | Q84216346 | ||
| Antenatal Counseling Regarding Resuscitation and Intensive Care Before 25 Weeks of Gestation | Q86043659 | ||
| Newborn screening for metabolic diseases: saving children's lives and improving outcomes | Q88002940 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 194-200.e3 | |
| P577 | publication date | 2018-04-13 | |
| P1433 | published in | The Journal of Pediatrics | Q7743611 |
| P1476 | title | Initial Metabolic Profiles Are Associated with 7-Day Survival among Infants Born at 22-25 Weeks of Gestation. | |
| P478 | volume | 198 |
| Q91045440 | Association between newborn screening analytes and hypoxic ischemic encephalopathy |
| Q100409287 | Newborn metabolic vulnerability profile identifies preterm infants at risk for mortality and morbidity |
Search more.